Board of Directors
The Board of Director’s primary role is to establish direction, monitor the performance of managers, and oversee the financial accountability of Genetics Australia Holdings (GAH) on behalf of the shareholders. The current shareholders of GAH are Genetics Australia Co-Operative (40%) and URUS Group (60%). The board is made up of 5 directors, two of whom are elected by Genetics Australia Co-Operative, and 3 of whom are elected by URUS Group.
Meet the Board Members
Trevor Henry
(Chairman)
Maffra, Vic.
Trevor was appointed to the Board in May 2010 and has now served for over 10 years. Formerly a director of the Macalister Demonstration Farm Board for 10 years where he served 4 years as Chairman. Trevor was previously Deputy Chairman GAC from 2013 to 2015 and then served as Chairman from November 2015 June 2023. In June 2023 Trevor stepped down as Chairman of Genetics Australia Co-Operative Board to take a up the position of Chairman on the new Genetics Australia Holdings board. Trevor runs his own successful dairying operation in Gippsland, Victoria, and also often contributes High BPI bulls to our bull line-up.
Jonny O’Brien
Jonny is an experienced finance professional with diverse experience across Private Equity, M&A and business strategy. Today, Jonny owns and manages South Island, a farm management and development business, and consults widely across Australian agriculture. Jonny lives in Kolora and helps oversee a family dairy enterprise south of Simpson.
Huub te Plate
Shano, WI, USA
Huub te Plate leads GENEX as the Chief Executive Officer. Huub has 32 years of industry experience and has dedicated over 23 of those years to GENEX. He was an instrumental force in the cooperative’s international sales for more than 15 years before accepting his current role as CEO. He holds a steadfast commitment to the success of GENEX members and customers through elite cattle genetics, innovative solutions and technologies, and impactful herd care products.
Sander Flanderijn
Sander Flanderijn is the Chief Financial Officer at GENEX. Sander holds a master’s degree in business administration. He has over 18 years of experience in finance and first began his career as an auditor for KPMG. He later joined Koepon Holding where he served as the Finance Manager, Europe, for five years before accepting his current role at GENEX in 2019.
Gregg Topoleski
Gregg Topoleski serves as Chief Financial Officer for URUS. With over 23 years in Finance, he has developed a deep operation and strategic skillset that will complement the URUS leadership team. Before joining URUS, most recently, Gregg served as Finance Executive for Sciences and 3M/KCI. He started his career with GE in the Healthcare and Industrial Technologies divisions